Skip to Content

Awards

Investing in the future: Rolanette and Berdon Lawrence Bone Research Awards

The Lawrence Research Competition was established in 2006 to provide seed grants of $45,000 each to two promising investigators in metabolic or metastatic bone disease. Eligible projects include those that study bone metastases, bone health in cancer patients, bone formation, and bone biology. Through mechanisms such as the Rolanette and Berdon Lawrence Bone Research Awards, the Bone Disease Program reaffirms its commitment to fostering groundbreaking research and supporting talented, young investigators in bone research careers.

Finalists are chosen from a large pool of outstanding investigators. Applicants represent a wide range of scientific expertise and approaches to bone research. 

2009 Rolanette and Berdon Lawrence Research Awards Submission Guidelines

Past Research Award Winners:

2009

  • "The Regulatory Role of E-Selectin Lignad-1 in Bone Remodeling"
    Tao Yang, Ph.D.
    Molecular and Human Genetics
    Baylor College of Medicine
  • "An Essential Role of TAK 1 in M-CSF-induced Survival of Monocyte/Osteoclast Progenitors
    Bette Lamothe, Ph.D.
    Experimental Therapeutics
    M. D. Anderson Cancer Center

2008

  • “A Mouse Model to Examine the Biology and Genetics of Osteosarcoma Metastasis”
    Lawrence A. Donehower, Ph.D.
    Department of Molecular Virology and Microbiology
    Baylor College of Medicine
  • “A Variant of Human Steroid Receptor Coactivator 1 (SRC1) Diminishes Co-Activation is Associated With Loss of Bone Mineral Density”
    Steffi Oesterreich, Ph.D.
    Lester & Sue Smith Breast Center
    Baylor College of Medicine
  • "Role of C-Reactive Protein in Myeloma Bone Disease"
    Qing Yi, MD, Ph.D.
    Department of Lymphoma and Myeloma
    M.D. Anderson Cancer Center

2007

2006

  • "Role of Collagen Prolyl 3-Hydroxylation in Bone Formation and Human Disease"
    Roy Morello, Ph.D.
    Baylor College of Medicine
    Department of Molecular and Human Genetics 
  • "Characterization of NO66, an Osx Interacting Protein During Osteoblast Differentiation and Bone Formation"
    Krishna M. Sinha, Ph.D.
    Department of Molecular Genetics
    The University of Texas-M. D. Anderson Cancer Center 

Past Poster Award Winners:

  • “Role of the Trps1 Transcriptional Repressor in Regulation of Signaling Cross-Talk During Endochondral Bone Formation”
    Dobrawa Napierala, Ph.D.
    Baylor College of Medicine
  • “Heterotopic bone formation in atherosclerotic vessels”
    Elizabeth Salisbury, B.S.
    Baylor College of Medicine
  • “Regulation of the osteoblast-specific transcription factor Osterix by NO66, a Jumonji family histone demethylase”
    Krishna Sinha, Ph.D., M.D.
    M.D. Anderson Cancer Center

Related Labs

Related Research


© 2009 The University of Texas M. D. Anderson Cancer Center